Overview
Odelaisy Triana-Leon practices practicing medicine in Madrid, Spain.
Their clinical expertise encompasses Graft Versus Host Disease (GvHD) and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Odelaisy Triana-Leon
Is Odelaisy Triana-Leon a top-rated expert for Graft Versus Host Disease (GvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Odelaisy Triana-Leon is classified as an Experienced expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Odelaisy Triana-Leon participate in research or clinical trials?
Yes. Odelaisy Triana-Leon has published 12 articles and abstracts on conditions like Graft Versus Host Disease (GvHD). You can view a list of Odelaisy Triana-Leon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Graft Versus Host Disease (GvHD)Triana-Leon isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Neurotoxicity SyndromesTriana-Leon isExperienced. Learn about Neurotoxicity Syndromes.